iShares Biotechnology ETF IBB
212.50 USD -0.93 (-0.44%)
At closeNov 13, 2026, 6:02 PM EST
211.69 -0.81 -0.38%
After hours · Nov 13, 6:02 PM ET
210.48 Day range 213.50
159.68 52-week range 222.29
- YTD
- +25.91%
- 1 year
- +30.11%
News
benzinga.com Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain? Biotech ETFs face key FDA catalysts as Summit Therapeutics' decision and the Hims-Lilly GLP-1 deal put XLV, IBB and XBI in focus.
fool.com Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investors The iShares U.S. Pharmaceuticals ETF offers a lower expense ratio and a significantly higher dividend yield than the iShares Biotechnology ETF. The iShares Biotechnology ETF provides exposure to a…
zacks.com Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001.
247wallst.com $10,000 in Vanguard's Health Care ETF in 2004 Grew to $93,915, and It Still Charges 0.09% A single health care ETF launched two decades ago at rock-bottom cost has quietly compounded into a sum that surprises most investors, but whether its three closest rivals can match it depends…
benzinga.com Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
247wallst.com Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs Regeneron (NASDAQ:REGN | REGN Price Prediction) shares rose 13.55% in Friday's session, trading at $929.69 as of 9:45 AM ET on Oct 30, 2026. For a biotech worth roughly $94.
zacks.com Should You Invest in the iShares Biotechnology ETF (IBB)? Launched on February 5, 2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity…
zacks.com ETFs That You May Consider Amid a Strengthening Biotech Outlook Drug innovation, AI and rising M&A activity are boosting biotech optimism. Discover ETFs offering exposure to the sector.
fool.com Invesco's RSPH or iShares' IBB: Which Healthcare ETF Is the Better Long-Term Buy? Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and a higher dividend yield than iShares Biotechnology ETF. iShares Biotechnology ETF provides concentrated biotech exposure…
cnbc.com Biotech stocks are surging. How investors can play the new drug innovation boom Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
fool.com Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy? Here's how pharmaceutical stocks compare to biotech in terms of risk, rewards, and costs.
defenseworld.net iShares Biotechnology ETF $IBB Shares Sold by Fairvoy Private Wealth LLC Fairvoy Private Wealth LLC cut its stake in shares of iShares Biotechnology ETF (NASDAQ: IBB) by 58.0% in the undefined quarter, according to the company in its most recent 13F filing with the…
benzinga.com Dow Jones Climbs to 52,000 While Chips Bleed on Rate-Hike Fears: Stock Market Today Hot inflation data fuels Fed rate-hike bets, hammering chip and AI-hardware stocks while the Dow tops 52,000 and small caps hold gains; gold rebounds.
247wallst.com Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher Healthcare is drawing fresh buying as money moves away from the market's popular technology trade, and one messenger RNA (mRNA) name is pulling well ahead of the pack. Moderna (NASDAQ:MRNA | MRNA…
benzinga.com Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today The Nasdaq 100 fell 1% by midday Wednesday after September CPI topped forecasts, pushing Treasury yields and rate-hike bets higher.
fool.com Better Buy: Fidelity Health Care ETF (FHLC) or iShares Biotechnology ETF (IBB)? Fidelity MSCI Health Care Index ETF offers a significantly lower expense ratio of 0.08% compared to 0.44% for the iShares Biotechnology ETF. iShares Biotechnology ETF is more concentrated, with 87%…
etftrends.com From Laggard to Leader: The Surprising Comeback of Healthcare Healthcare stocks have finally stepped back into the spotlight. After spending much of the past several years in the shadow of technology and AI, the sector has quietly emerged as one of the year's…
fool.com Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH? The iShares U.S. Healthcare ETF offers a lower expense ratio and a higher dividend yield than the iShares Biotechnology ETF. The iShares Biotechnology ETF provides concentrated exposure to over 200…
benzinga.com Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7% Stocks fell and small caps slumped Wednesday as the 30-year Treasury yield hit 5.7%, a 24-year high, with Fed minutes and bond auctions ahead.
benzinga.com S&P 500, Nasdaq Hit Records, Power Stocks Rally on Google's Nuclear Deal: Stock Market Today S&P 500 and Nasdaq 100 hit records as the 10-year yield retreats from a 24-year high; Constellation Energy jumps on a Google nuclear deal.
fool.com Better Healthcare ETF: Vanguard's Broad VHT vs. the iShares Biotechnology-Focused IBB The Vanguard Health Care ETF offers a broad healthcare focus with a significantly lower expense ratio of 0.09% compared to its peer. The iShares Biotechnology ETF saw a higher 1-year total return but…
247wallst.com Big Pharma Got Its Tariff Exemption. The Biotech ETF Barely Blinked A 100% tariff on imported drugs just expanded to cover every drugmaker in the country, yet the biotech market's most closely watched fund treated it like a non-event. The reason says everything about…
fool.com Better Healthcare ETF: iShares Biotechnology-Focused IBB vs. Simplify's Broad PINK The iShares Biotechnology ETF carries a lower expense ratio and significantly larger assets under management (AUM) than the Simplify Health Care ETF. The Simplify Health Care ETF provides broader…
defenseworld.net 104,009 iShares Biotechnology ETF $IBB Shares Sold by Envestnet Asset Management Inc. Envestnet Asset Management Inc. decreased its stake in iShares Biotechnology ETF (NASDAQ: IBB) by 8.5% in the second quarter, according to the company in its most recent Form 13F filing with the…
benzinga.com S&P 500 Erases Losses as US, Iran Reportedly Discuss Hormuz Deal: Stock Market Today Stocks pared a sharp morning selloff after sources said US and Iranian negotiators are discussing a phased deal to reopen the Strait of Hormuz.
fool.com XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.
benzinga.com Nasdaq 100 Flirts with Records, Oil Sinks for Fifth Day: Stock Market Today The Nasdaq 100 carved out a fresh intraday record by midday Tuesday as the artificial intelligence trade powered ahead.
benzinga.com Nasdaq 100 Flirts with Records, Oil Sinks for Fifth Day: Stock Market Today Nasdaq 100 printed an intraday record on AI enthusiasm while financials slid nearly 2% and crude fell for a fifth straight session.
benzinga.com Nasdaq 100 Rallies as Oil Slides, Yields Retreat: Stock Market Today Wall Street snapped a two-day losing streak Thursday as oil retreated from its geopolitical spike and the 10-year Treasury yield slipped back below 5%. Chipmakers led the rebound, with Intel, AMD and…
benzinga.com S&P 500 Gains, Crude Falls Ahead Of Fed's Expected First Hike Since 2023: Stock Market Today Crude tumbles 3.6% on a Saudi pipeline restart, easing yields and lifting chips, while the Fed prepares its first rate hike in nearly three years.
benzinga.com QUICK SPARK: Amgen Stock Eyes Worst Day Since October 2000 Amgen sank 9.8% Tuesday after Novartis' pelacarsen missed its Phase 3 endpoint, casting doubt on rival Lp(a) drug olpasiran.
benzinga.com S&P 500, Nasdaq Slip as $98 Brent Reignites Inflation Fears: Stock Market Today Crude near $98 pushes the 10-year Treasury yield above 4.8% for the first time since 2023, hammering the Dow as traders price a Fed rate hike next week.
benzinga.com What's Going On With Amgen Stock Tuesday? AMGN stock dips 9% after rival drug trial misses goal. Discover Amgen key support levels, technical outlook, and analyst price targets
benzinga.com Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.
benzinga.com Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.
benzinga.com Nasdaq 100 Falls As Warsh Revives Rate Hike Bets: Stock Market Today Fed Chair Kevin Warsh said underlying inflation has not improved, pushing September hike odds to 60%, lifting the 2-year yield
benzinga.com Memory Stocks Slide as Trump Threatens 50% Tariffs on Canadian Autos, Steel in 2027: Stock Market Today US equities mixed as tech stocks drag Nasdaq 100 lower, Trump escalates trade fight with Canada, and Fed Chair Warsh speaks at Jackson Hole.
benzinga.com Bessent's Bond Rescue Fizzles, Walmart Craters 9%: Stock Market Today Long-end Treasury yields snapped back toward 20-month highs; Walmart posted its worst session in four years.
benzinga.com Biotech Is Booming, But These 2 Stocks Missed the Memo The iShares Biotechnology ETF is trading at new highs and 18 out of its top 20 constituents are green for the year.
benzinga.com Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For MRK, MRNA's cancer vaccine breakthrough could revive the mRNA trade, putting biotech and genomics ETFs back in focus.
benzinga.com Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today Treasury's expanded long-bond buybacks knocked yields off 20-month highs and sank the dollar, as gold soars.
benzinga.com Nasdaq Drops, Chip Stocks Crater As Bond Yields Bite: Stock Market Today Fabrinet's margin miss triggered a brutal selloff across the stock market today, while $91 Brent kept equities under pressure
benzinga.com SanDisk Rips 10%, Micron Rises 6% as AI Memory Frenzy Builds: Stock Market Today Memory chipmakers ripped higher Monday after Washington pushed Apple away from Chinese DRAM suppliers, while the 30-year yield hit a fresh 19-year peak.
benzinga.com ‘Never Happened in History,’ Ex-Bridgewater Exec Warns AI Market Is Priced to Perfection Former Bridgewater exec Bob Elliott warns the AI stock rally is an "expectations mania" built on unrealistic growth assumptions.
benzinga.com Oil Jumps 3%, Yields Climb as Hormuz Hopes Fade: Stock Market Today Crude surges above $80 and the 10-year yield hits an August high as an Iran-US deal on the Strait of Hormuz slips away, stalling Wall Street's record run.
benzinga.com Moderna Advances Ebola Vaccine Into Human Testing Moderna starts Phase 1 trials for Ebola vaccine mRNA-1469. See premarket MRNA stock reaction, analyst updates, and ETF exposure.
benzinga.com Chip Rout Drags Nasdaq 100 Lower, Oil Climbs: Stock Market Today A deepening chipmaker slide pulls all major U.S. indexes lower Tuesday while oil climbs on a Strait of Hormuz strike and defensive sectors led the tape.
benzinga.com Chip Rout Drags Nasdaq 100, Oil Sinks Below $69: Stock Market Today Semiconductors cratered Friday, dragging the stock market lower, while health care and software led a rotation and oil sank below $69
benzinga.com S&P 500 Rebounds Ahead Of Micron Test, Oil Drops To $70: Stock Market Today U.S. stocks rebounds Wednesday as oil sank below $70 on holding the Iran ceasefire, small caps hit a record, gold slides and traders await Micron earnings.
benzinga.com Why Is Natera Stock Gaining Tuesday? Natera (NTRA) stock rallies following a key NCCN guideline update for Signatera. Also, check out the full NTRA stock analysis.